Mwanzo8QQ • FRA
add
AbCellera Biologics Inc
Bei iliyotangulia
€ 1.78
Bei za siku
€ 1.78 - € 1.78
Bei za mwaka
€ 1.70 - € 3.79
Thamani ya kampuni katika soko
588.01M USD
Wastani wa hisa zilizouzwa
448.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 4.24M | -57.45% |
Matumizi ya uendeshaji wa biashara | 24.40M | -4.55% |
Mapato halisi | -45.62M | -12.34% |
Kiwango cha faida halisi | elfu -1.08 | -164.04% |
Mapato kwa kila hisa | -0.15 | -7.14% |
EBITDA | -57.33M | -14.54% |
Asilimia ya kodi ya mapato | 13.90% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 605.27M | -13.29% |
Jumla ya mali | 1.34B | -8.13% |
Jumla ya dhima | 321.23M | -3.59% |
Jumla ya hisa | 1.02B | — |
hisa zilizosalia | 298.48M | — |
Uwiano wa bei na thamani | 0.52 | — |
Faida inayotokana na mali | -11.58% | — |
Faida inayotokana mtaji | -14.16% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -45.62M | -12.34% |
Pesa kutokana na shughuli | -11.55M | 72.30% |
Pesa kutokana na uwekezaji | 7.94M | -73.47% |
Pesa kutokana na ufadhili | 5.97M | 110.88% |
Mabadiliko halisi ya pesa taslimu | 2.94M | 130.17% |
Mtiririko huru wa pesa | -63.60M | -21.59% |
Kuhusu
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2012
Makao Makuu
Tovuti
Wafanyakazi
596
